Circulating Interleukin‐6 and High‐Sensitivity C‐Reactive Protein Decrease After Periodontal Therapy in Otherwise Healthy Subjects
Authors:
- César A. MeschiariCMCésar A. Meschiari
- Carlos A. SorgiCarlos A. Sorgi
- Maria C.P. SaraivaMSMaria C.P. Saraiva
- Ana M. de SouzaASAna M. de Souza
- Lúcia H. FaccioliLFLúcia H. Faccioli
- José E. Tanus‐SantosJTJosé E. Tanus‐Santos
- Arthur B. NovaesANArthur B. Novaes
- Raquel F. GerlachRGRaquel F. Gerlach
- 1 April 2009
- journal article
- research article
- Published by Wiley in Journal of Periodontology
- Vol. 80 (4) , 594-602
Abstract
Background: Periodontal disease has been associated with many chronic inflammatory systemic diseases, and a common chronic inflammation pathway has been suggested for these conditions. However, few studies have evaluated whether periodontal disease, in the absence of other known inflammatory conditions and smoking, affects circulating markers of chronic inflammation. This study compared chronic inflammation markers in control individuals and patients with periodontal disease and observed whether non‐surgical periodontal therapy affected inflammatory disease markers after 3 months.Methods: Plasma and serum of 20 controls and 25 patients with periodontal disease were obtained prior to and 3 months after non‐surgical periodontal therapy. All patients were non‐smokers, they did not use any medication, and they had no history or detectable signs and symptoms of systemic diseases. Periodontal and systemic parameters included probing depth, bleeding on probing, clinical attachment level, hematologic parameters, as well as the following inflammatory markers: interleukin (IL)‐6, high‐sensitivity C‐reactive protein (hs‐CRP), CD40 ligand, monocyte chemoattractant protein (MCP)‐1, soluble P‐selectin (sP‐selectin), soluble vascular adhesion molecule (sVCAM)‐1, and soluble intercellular adhesion molecule (sICAM)‐1.Results: There were no differences in the hematologic parameters of the patients in the control and periodontal disease groups. Among the tested inflammatory markers, IL‐6 concentrations were higher in the periodontal disease group at baseline compared to the controls (P = 0.006). Therapy was highly effective (P P = 0.001 and P = 0.006, respectively). Our results also suggest that the CD40 ligand marker may have been different in the control and periodontal disease groups prior to the therapy (P = 0.009).Conclusions: In apparently otherwise healthy patients, periodontal disease is associated with increased circulating concentrations of IL‐6 and hs‐CRP, which decreased 3 months after non‐surgical periodontal therapy. With regard to the CD40 ligand, MCP‐1, sP‐selectin, sVCAM‐1, and sICAM‐1, no changes were seen in the periodontal disease group between baseline and 3 months after therapy.Keywords
This publication has 53 references indexed in Scilit:
- Effects of Periodontal Therapy on Glycemic Control and Inflammatory MarkersJournal of Periodontology, 2008
- Severe periodontitis in young adults is associated with sub‐clinical atherosclerosisJournal of Clinical Periodontology, 2008
- A systematic review and meta‐analyses on C‐reactive protein in relation to periodontitisJournal of Clinical Periodontology, 2008
- Periodontitis is characterized by elevated PAI‐1 activityJournal of Clinical Periodontology, 2007
- Periodontal infections cause changes in traditional and novel cardiovascular risk factors: Results from a randomized controlled clinical trialAmerican Heart Journal, 2006
- Periodontal infection as a possible severity factor for rheumatoid arthritisJournal of Clinical Periodontology, 2005
- A Pilot Study Into Measurements of Markers of Atherosclerosis in PeriodontitisJournal of Periodontology, 2005
- Periodontal disease, but not edentulism, is independently associated with increased plasma fibrinogen levelsThrombosis and Haemostasis, 2004
- Inflammation in atherosclerosisNature, 2002
- Porphyromonas gingivalis Infection Accelerates the Progression of Atherosclerosis in a Heterozygous Apolipoprotein E–Deficient Murine ModelCirculation, 2002